Neuroleptic induced tardive dyskinesia in a patient on treatment for schizophrenia: case report.
In this case, a thirty six year old patient on treatment for schizophrenia is described with severe tardive dyskinesia. The most likely cause is long term treatment with two highly potent typical antipsychotic medications. The patient was initially treated with Benzhexol, an anticholinergic agent with the potential to induce or aggravate the disorder. This case discusses the common presentation and management of neuroleptic induced tardive dyskinesia.
Atwoli
L
L
Department of Psychiatry, Moi University, School of Medicine, P.O Box 4606-30100, Eldoret, Kenya.
Manguro
G
G
Owiti
P
P
Ndambuki
D
D
D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects*; D018680:Cholinergic Antagonists / Q000009:adverse effects*; D004409:Dyskinesia, Drug-Induced / Q000175:diagnosis* / Q000188:drug therapy; D005260:Female; D006801:Humans; D012560:Schizophrenia, Catatonic / Q000150:complications / Q000188:drug therapy*; D016896:Treatment Outcome; D014282:Trihexyphenidyl / Q000009:adverse effects*
D014150:Antipsychotic Agents; D018680:Cholinergic Antagonists; D014282:Trihexyphenidyl